Skip to main content

Table 2 Elimination of water-soluble substances and bilirubin during the first ADVOS treatment of each patient

From: Advanced organ support (ADVOS) in the critically ill: first clinical experience in patients with multiple organ failure

  Before ADVOS (mg/dl) After ADVOS (mg/dl) Relative elimination for each ADVOS treatment (%) Rate of treatments showing a reduction of serum levels (%)
Creatinine (mg/dl) 1.65 (1.15, 2.36) 1.13** (0.87, 1.82) − 24% (− 49%, − 5%) 69
BUN (mg/dl) 28 (17, 44) 16** (11, 23) − 48% (− 62%, − 17%) 84
Ammonia (µmol/l) 65 (58, 87) 58** (45, 72) − 19% (− 60%, − 8%) 91
Bilirubin (mg/dl) 4.5 (0.9, 19.1) 4.1** (0.9, 12.6) − 20% (− 34%, − 4%) 76
  1. Median (IQ25, IQ75). Non-parametric paired Wilcoxon test
  2. **p < 0.01. Median treatment duration 18.5 h (range 8.25, 22.0)